Related by context. All words. (Click for frequent words.) 70 Budesonide foam crofelemer 70 Presents Positive 70 recurrent metastatic ovarian cancer 70 Crofelemer budesonide foam 69 Initiates Phase II 68 Begins Dosing 68 recombinant PSMA vaccine 68 cladribine Cladribine Tablets 68 Submits Biologics License Application 68 Pruvel TM 67 Initiates Phase III 67 evaluating mipomersen 67 TRIOLEX HE# APOPTONE HE# 67 dimebon latrepirdine 67 Demonstrates Positive 67 Biogen Genentech 66 Combination REOLYSIN R 66 Completes Patient Enrollment 66 includes TOLAMBA TM 66 LymphoStat B belimumab 66 Aradigm Logo 66 humanized therapeutic 66 ® bortezomib 66 palonosetron hydrochloride Injection Dacogen 66 MediGene focuses 66 kidney urologic 66 advanced compound INCB# 66 Submits Supplemental 66 opioid naive 66 Aeolus Pharmaceuticals Announces 66 evaluating picoplatin 65 Namenda Memantine HCl 65 Initiates Enrollment 65 approved incretin mimetic 65 FDA Approves Novel 65 VEGFR2 inhibitor 65 combining voreloxin 65 Meets Primary Endpoint 65 successfully commercialize Iluvien 65 brand ciclesonide HFA 65 CD# CEA 65 CIMZIA r certolizumab pegol 65 relapsing remitting MS RRMS 65 CYT# potent vascular disrupting 65 Amigal TM 65 TransVax 64 TRACON Pharmaceuticals 64 include Healive TM 64 Submits NDA 64 MCSP respectively 64 Telik logo TELINTRA 64 oral nucleoside analogue 64 immunotherapeutic approaches 64 Shows Efficacy 64 Initiate Phase III 64 cytidine nucleoside analog 64 semi synthetic lipoglycopeptide 64 CG# oncolytic virus 64 candidates Azedra TM 64 4SC AG ISIN DE# 64 IMiDs ® 64 CINQUIL 64 sapacitabine CYC# 64 Salix Pharmaceuticals Announces 64 indolent follicular non 64 Drug Shows Promise 64 XL# anticancer compounds 64 Completes Enrollment 64 CTAP# Capsules 64 Drug Candidate 64 neuro inflammatory disorders 64 HGS ETR1 mapatumumab 63 Transition Therapeutics Announces 63 plus prednisone prednisolone 63 PEGylated docetaxel 63 Phase 2b Clinical Trial 63 Ribavirin causes 63 Sangamo BioSciences Announces 63 Symbollon Pharmaceuticals Announces 63 systemic juvenile idiopathic 63 nilotinib Tasigna ® 63 Drug Fails 63 SUSTENNA TM 63 infectious diseases autoimmune diseases 63 Granted Orphan Drug 63 receiving XGEVA 63 novel VDA molecule 63 Bayer HealthCare Onyx Pharmaceuticals 63 Shows Promise Against 63 Initiates Clinical Trial 63 vascular occlusive diseases 63 Phase 2b Trial 63 M# rationally 63 fusion enhancers 63 Telik Announces 63 PRN FDA Approves 63 SILENOR TM doxepin HCl 63 concomitant cardiac 63 JAK2 Inhibitor 63 commercialize CorMedix drug 63 non porcine pancreatic 63 Phase IIb Trial 63 reduce serum phosphate 63 Archexin 63 HEPLISAV TM hepatitis B 63 AAG geldanamycin analog 63 Hormone Refractory Prostate Cancer 63 albiglutide 63 Treatment Shows Promise 63 Desvenlafaxine Succinate 63 Initiates Dosing 63 Romidepsin 63 Plicera TM 63 Aloprim TM allopurinol sodium 63 Dean Koontz Bantam FP 63 FOLFOX6 chemotherapy regimen 63 memantine HCl 63 Glufosfamide 63 R Bortezomib 63 Receives Fast Track 63 Trastuzumab DM1 63 Files IND 63 R sorafenib tablets 63 FUSILEV enhances 63 R rilonacept Injection 62 developing ostarine selective 62 Synta Announces 62 YOUR LOCAL ANIMAL SHELTER 62 Investigational Oral 62 SPRYCEL ® 62 interferon gamma 1b 62 ® decitabine 62 candidate CRLX# 62 Submits Response 62 Improves Outcomes 62 By Miriam Reimer 62 PLX STROKE targeting 62 Achieves Primary Endpoint 62 mitoxantrone plus 62 oral picoplatin 62 Warner Chilcott Actonel 62 Receives Orphan Drug Designation 62 next generation URAT1 62 relapsed MM 62 Demonstrates Significant 62 refractory chronic lymphocytic 62 Healthbeat Report 62 Vildagliptin 62 TRIOLEX ™ 62 smoldering multiple myeloma 62 R MSCRAMM 62 ragweed allergy immunotherapeutic 62 IMPDH inhibitor 62 Poorly Controlled 62 antiangiogenesis therapies 62 PORxin TM platforms 62 respiratory allergy dermatological 62 HIV coinfected 62 Phase Ib IIa 62 Patients Treated With 62 included exfoliative dermatitis 62 vaccine RiVax ™ 62 oral prodrug 62 clinical trials Archexin 62 induced mucositis 62 Hsp# Inhibitor 62 Dyax logo 62 Lupus Drug 62 acyclovir Lauriad R 62 Parlay Entertainment Announces 62 Idenix Pharmaceuticals Reports 62 novel emulsion formulation 62 Antibody Drug Conjugate 62 MEK Inhibitor 62 basal cell carcinoma squamous 62 MSCRAMM ® 62 ZACTIMA TM ZD# 62 Vidaza ® 62 Clot Busting 62 Clinical Trial Results 62 dirucotide MBP# 62 evaluating tivozanib 62 Personalized Immunotherapy 62 Newly Diagnosed Multiple Myeloma 62 demonstrated antitumor activity 62 interferon alpha IFN 62 toenail onychomycosis 62 GRNOPC1 contains 62 XP# XP# 61 Perifosine KRX 61 Novel Oral 61 TRAIL receptor antibody mapatumumab 61 naïve HCV 61 Relapsed Multiple Myeloma 61 multiple sclerosis psoriasis 61 signal detection CTSD 61 INSPIRE Trial Phase III 61 Refractory Hodgkin Lymphoma 61 Acute Exacerbations 61 baminercept 61 onychomycosis psoriasis acne 61 Atripla combines 61 bone marrow reticulin deposition 61 Albuferon albinterferon alfa 2b 61 Mg Usa 61 developing Bicifadine serotonin 61 Shows Promising 61 asthma rheumatoid arthritis 61 CysDisplay R 61 lintuzumab SGN 61 VIVUS Announces 61 Relapsed Refractory 61 rALLy 61 CCR9 antagonist 61 Investigational Treatment 61 subcutaneous PRO 61 candidate SMaRT Replacement 61 Advanced Melanoma 61 Zemplar Capsules 61 Severe hypersensitivity reactions 61 class mGluR5 inhibitor 61 Barr Receives Approval 61 Improves Survival 61 Naive Patients 61 Pegloticase 61 orally administered synthetic retinoid 61 Randomized Double blind 61 AVN# Phase 61 particularly SANCTURA XR 61 By JENNIFER LEARN 61 INVEGA ® SUSTENNA ® 61 Initiate Clinical Trial 61 diabetes irritable bowel 61 Demonstrate Significant 61 Pivotal Phase III 61 Presents Preclinical Data 61 delivers preprogrammed intermittent 61 vaccine RiVax TM 61 COPEGUS R 61 HuMax TAC 61 pralatrexate injection folate analogue 61 Peginterferon Alfa 2b 61 tribulations Groenveld 61 galiximab 61 BCG refractory carcinoma 61 developing Surfactant Therapies 61 SAR# [004] 61 pegylated interferon peg IFN 61 Hypertensive adverse reactions 61 Complicated Skin 61 ® adefovir dipivoxil 61 Antitumor Activity 61 Rheumatoid Arthritis Drug 61 post herpetic 61 use transdermal sumatriptan 61 retinal vein occlusion induced 61 erlotinib Tarceva R 61 rheumatoid arthritis inflammatory bowel 61 CytoCore develops cost 61 Shigatoxin producing E. coli 61 Terra Incognita Golden 61 NDA Submission 61 Tezampanel 61 Acute leukemia 61 MKC# MT 61 elderly myelodysplastic syndromes 61 Trial Evaluating 61 CYP#A# CYP#D# 61 involuntary dyskinetic movements 61 By Joseph Woelfel 61 Gentle Path compound 61 lead molecular radiotherapeutic 61 pipeline ImmunoGen collaborators 61 Pharmacyclics Announces 61 www.telik.com 61 Patient Enrollment 61 ciprofloxacin hydrochloride 61 Boehringer Ingelheim MedImmune 61 reactive airways disease 61 SECOND SPOT DISPATCHES FROM 60 AKT inhibitor 60 Regenerative Cell 60 TRANSDUR ® 60 Pooled Analysis 60 oncolytic virus therapies 60 5 lipoxygenase inhibitor 60 Orally Active 60 Fibrin MB 60 FDA Approves Drug 60 Launches Generic Version 60 hematological cancers notably 60 Vicriviroc 60 lenalidomide Revlimid R 60 castration resistant hormone refractory 60 Lung Transplant Patients 60 immunocompetent adults 60 psychiatric disorders ATI 60 Ph + acute lymphoblastic 60 glaucoma ischemia 60 alvespimycin 60 dasatinib Sprycel ® 60 TO AVOID PREGNANCY WHILE 60 CYP#A# substrate 60 By TED HARBIN 60 Vasogen Announces 60 hypertrichosis occurred 60 Nuvelo Announces 60 DIFICID ™ 60 generation purine nucleoside 60 FDA Okays 60 By Kat Zeman 60 Angiotensin receptor blockers 60 novel synthetic PEGylated 60 ospemifene 60 processors visit www.tensilica.com 60 deCODE ProstateCancer TM 60 HER2 Positive Breast Cancer 60 markets Testim ® 60 Inhibitex Reports 60 Elagolix 60 Severe Sepsis 60 doxepin HCl 60 Amgen Neulasta R 60 Alimentary Tract 60 commercialize NicVAX 60 Simulations Plus Reports 60 Cardium Therapeutics TM 60 mGluR5 NAM 60 Nicotine Vaccine 60 candidate XP# 60 PEGylated Fab fragment 60 factor TNF receptor 60 allosteric modulator PAM 60 Ecometals Announces 60 Carboplatin Paclitaxel 60 EDEMA3 trial 60 Cholesterol Lowering Drug 60 Pagoclone 60 RAS MAPK pathway 60 High Dose quadruples 60 pentadentate logo R 60 precision intravascular 60 trastuzumab DM1 T DM1 60 generation PNP inhibitor 60 read Palintologist 60 Dasatinib 60 alfa 2a 60 MULLIGAN FAMILY FUN CENTER 60 Letairis ambrisentan 60 rash pruritus nausea 60 BY DANNY GALLAGHER 60 humanized interleukin 6 60 See www.bg group.com 60 Vertex hepatitis C 60 Plaque Psoriasis 60 SUTENT ® 60 TM Aganocide 60 Vaccine Shows Promise 60 By Jonas Elmerraji 60 Vaccine Prevents 60 Pruvel ™ prulifloxacin 60 SANCTURA XR NEBIDO 60 acetonide FA 60 Oral Fingolimod 60 Peginterferon alfa 2b 60 AzaSite ISV 60 diseases osteoarthritis osteoporosis 60 Mg Uk 60 Onyx Pharmaceuticals Announces 60 sorafenib tablets 60 Phase 2a Trial 60 HCV Protease Inhibitor 60 Solzira TM 60 naloxol derivative 60 tramiprosate Alzhemed TM 60 anthracycline containing 60 Clostridium Difficile Associated 60 Blood Pressure Drug 60 novel therapeutic antibodies 60 CG# [003] 60 infectious diseases autoimmune 60 R Saizen R 60 metastatic ocular 60 Staphylococcus aureus Immune Globulin 60 Systemic Delivery 60 trap antimatter atoms 60 Dementia Related Psychosis 60 Games visit www.cdcgames.net 60 miconazole Lauriad ® 60 maximally tolerated lipid lowering 60 LymphoStat B TM 60 INVEGA ® 60 TM pralatrexate injection 60 Anflu R influenza 60 rheumatoid arthritis osteoarthritis ankylosing 60 Gastrointestinal Stromal Tumors 60 Golimumab 60 daily injectable lipoglycopeptide 60 Multiple Sclerosis Rheumatoid Arthritis 60 number NCT# ClinicalTrials.gov 60 Treatment Naïve 60 aldehyde dehydrogenase ALDH2 deficiency 60 TRAIL receptor antibodies 60 headache nasopharyngitis 60 Treatment Reduces 60 Metastatic Melanoma 60 Momenta Pharmaceuticals Announces 59 Preska imposed 59 membranous nephritis 59 hypereosinophilic syndrome 59 Shiwakoti wrinkled 59 topical gel formulation 59 Lung Cancer Vaccine 59 Spectrum Pharmaceuticals Announces 59 decompensated liver disease 59 Vitrasert R 59 Study Shows Promise 59 Improved Progression 59 including eniluracil ADH 59 Demonstrates Efficacy 59 dihydroergotamine mesylate DHE 59 Adjuvant Treatment 59 HGS ETR2 59 evaluating satraplatin plus 59 Diabetic Foot Ulcer 59 Chronic Hepatitis C 59 DEB# 59 Taro Receives 59 ATRA IV 59 Sanofi Pasteur ALVAC canary 59 unique alkylating agent 59 inflammation autoimmune diseases 59 peptidic compound 59 Pfizer inhaled insulin 59 DASISION 59 Edge STudy 59 Receives Orphan Drug 59 Granulocyte Colony Stimulating Factor 59 Postherpetic neuralgia PHN 59 psoriasis Crohn disease 59 LEVADEX TM 59 investigational monoclonal antibody 59 RNAi Therapeutic 59 5 fluorouracil leucovorin 59 TLR7 agonist 59 known sulfonamide allergy 59 FDA Accepts 59 OMNARIS HFA 59 accumulate preferentially 59 Repligen Reports 59 cause mesothelioma asbestosis 59 achieved CCyR 59 INTEGRILIN R eptifibatide Injection 59 Prostate Cancer Vaccine 59 XL# XL# XL# XL# 59 anaphylactic reactions bronchospasm 59 Elotuzumab 59 Rheumatoid Arthritis Patients 59 Bosutinib 59 resistant hormone refractory 59 delivers fluocinolone acetonide FA 59 oropharyngeal candidiasis OPC 59 cystic fibrosis inflammation autoimmune 59 humanised monoclonal antibody 59 Demonstrated Significant 59 Employment Inducement Awards 59 chemotherapy molecularly targeted 59 Novolimus 59 Xeloda ® 59 Present Preclinical Data 59 Intervention Effectiveness 59 syndrome overactive bladder 59 capromab pendetide kit 59 candidate TNFerade biologic 59 proven DPUs visit www.tensilica.com 59 advanced metastatic renal 59 TNF Tumor Necrosis Factor 59 Exelixis compounds 59 Vidaza R 59 AVI BioPharma Announces 59 ONCONASE R 59 agents Tabun Sarin 59 phenylketonuria PKU developed 59 selective inverse agonist 59 Takeda Kyowa Hakko Kirin 59 Neovascular 59 orally administered inhibitor 59 Allos retains exclusive 59 TELINTRA R 59 TOCOSOL Camptothecin 59 Immunomedics Announces 59 Sitebrand Announces 59 MetroGel 59 neuromuscular spasm 59 infliximab monotherapy 59 Perforomist ™ Inhalation Solution 59 Safinamide 59 registrational Phase 59 Terminbörse EUREX End 59 oral talactoferrin 59 antihistamines antidepressants 59 ELADUR ™ 59 Senetek PLC Announces 59 MAGE A3 ASCI 59 Panzem R NCD 59 Preclinical Data 59 Enbrel Remicade 59 delivery polymer matrix 59 Copegus R 59 Darinaparsin 59 Anthracycline 59 ocular formulation 59 HCl PEPCID ® famotidine 59 TBC# 59 Postmenopausal Osteoporosis 59 Treat Heart Failure 59 ACTEMRA TM 59 EGFr humanized monoclonal antibody 59 Lung Cancer Drug 59 Cash Dividend Declared 59 NSABP C 59 diabetic kidney 59 Paclitaxel Carboplatin 59 5 HT2A serotonin 59 CYT# QbG# 59 ALVESCO R 59 cytokine refractory 59 PANVAC VF 59 maximally tolerated dose 59 Combivir Kivexa 59 known dihydropyrimidine dehydrogenase 59 apomorphine hydrochloride 59 osteolytic bone disease 59 neovascular diseases 59 leukotriene receptor antagonists 59 Brentuximab Vedotin SGN 59 phase IIb study 59 Previously Treated 59 Capsules CII 59 PDE# 59 Dupuytren Disease 59 LPLD 59 pipeline GlycoPEG GCSF 58 Disease Modifying 58 methylnaltrexone bromide 58 Stargardt Macular Dystrophy SMD 58 EntreMed Presents 58 Gout Drug 58 RAPTIVA 58 receiving VELCADE 58 SinuNase TM 58 hyperphenylalaninemia HPA due 58 Anthrax Toxin 58 R lenalidomide 58 rheumatoid arthritis psoriatic arthritis 58 Collaborators Publish 58 Albuferon TM 58 oral rivaroxaban 58 R#/MEM # 58 Behcet uveitis 58 neovascular age 58 Peginterferon Alfa 2a 58 Sands Macao Venetian Macau 58 Gets FDA Clearance 58 Cimzia TM 58 Arthritis Drug 58 Anti VEGF 58 nasal calcitonin product 58 refractory metastatic 58 visilizumab 58 Epilepsy Drug 58 Preclinical Efficacy 58 Diamyd Medical Diamyd 58 Accelrys Announces 58 stage hypoxia activated 58 lupus hepatitis C 58 Rheumatoid Arthritis RA 58 lomitapide 58 FDA Clears 58 AirBoss Announces 58 Epothilones 58 acute peptic ulcer 58 eosinophilic asthma 58 Teva Provides Update 58 Vaxfectin TM 58 markets COLAZAL 58 By Laurelle Gilbert 58 PresbyLens ® 58 Tibotec Therapeutics division 58 rxRNA 58 By Alex Roarty 58 HIV RDEA# 58 transdermal estradiol gel 58 Tyrosine Kinase Inhibitor 58 INVEGA ™ 58 hepatitis C lupus 58 Announces Tentative Approval 58 Intravitreal injections 58 vapreotide acetate 58 TRANSDUR ™ 58 Phase 1a clinical 58 Heska Announces 58 CDK cyclin dependent 58 Ovitrelle R Serostim 58 Cutaneous T 58 www.BYETTA.com 58 spleen enlargement 58 Schizophrenia Drug 58 STELARA TM 58 dasatinib Sprycel 58 Veronate R 58 Therapy Improves 58 receptor tyrosine kinase inhibitor 58 Chronic Myeloid Leukemia 58 Huggins Cams Time 58 hypokalemia hypomagnesemia 58 bardoxolone methyl 58 Oral Laquinimod 58 Fludara ® 58 GERD migraine headaches 58 PEG irinotecan 58 aplindore 58 Fast Track Status 58 5 FU leucovorin 58 Panzem R 58 tumor angiogenesis inhibitors 58 DAVID ADDINGTON 58 basal insulin analogue 58 Known hypersensitivity 58 Mylan Receives Approval 58 cognitive impairment associated 58 Adenoviruses usually cause 58 Luveris R Ovidrel R 58 personalized cellular immunotherapy 58 IBS C 58 novel chimeric natriuretic 58 biologic antibody 58 Patients Receiving 58 JOULFERON 58 Phase III Trials 58 Entereg R 58 Geokinetics Announces 58 Polymerase Inhibitor 58 oral salmon calcitonin 58 Zavesca r 58 treat atopic dermatitis 58 Aryplase 58 Amgen Enbrel 58 Malignant Glioma 58 UGI Declares 58 Humanized Anti 58 Previously Untreated 58 thrombin component 58 diarrhea fatigue asthenia 58 please visit www.sucampo.com 58 proprietary intranasal insulin 58 Demonstrates Sustained 58 myocardial infarction ventricular fibrillation 58 Slows Progression 58 CRLX# 58 BRIM3 58 Bristol Myers Squibbs 58 Silodosin 58 Q#IR 58 Cojocaru correspondent 58 Atypical Hemolytic Uremic Syndrome 58 CCR2 antagonists 58 Prolongs Survival 58 CDP# 58 Parkinson disease monogenic diseases 58 discontinued Viread 58 Treatment Naive Patients 58 Sapacitabine 58 erlotinib Tarceva ® 58 Solazed TM 58 Anat Cohen Dayag 58 generation DACH Platinum 58 lupus multiple sclerosis 58 TELINTRA 58 systemic invasive fungal 58 diabetic peripheral neuropathic DPN 58 bronchospasm dizziness headache 58 unresectable tumors 58 Phase IIb Clinical Trial 58 GI motility disorders 58 androgen receptor modulator 58 Gene Linked 58 induced macular edema 58 Provectus Pharmaceuticals specializes 58 Metastatic Renal Cell Carcinoma 58 bronchial inflammation medicine 58 NMT Medical Announces 58 3D conformal radiation 58 taxane chemotherapy administered 58 Subgroup Analysis 58 Advanced Colorectal Cancer 58 Shows Statistically Significant 58 Thalomid ® 58 Zenvia ™ 58 HCV IET 58 Soft Tissue Sarcoma 58 Non inferiority 58 commercialize Aganocides 58 psoriasis rheumatoid arthritis 58 GLPG# 58 Phase 2a Clinical Trial 58 ® pramlintide acetate 58 relapsed ALL 58 Often Misdiagnosed 58 including cyclosporine methotrexate 58 Altera Nebulizer System 58 world safest multivalent 58 Relapsing Remitting Multiple Sclerosis 58 Sodium oxybate 58 TBC M4 58 Kuvan R 58 severe malignant osteopetrosis 58 homozygous familial hypercholesterolemia 58 Tyrosine Kinase Inhibitors 58 By DAVID SCHEPP 58 budesonide foam 58 Adenoviral 58 ceftazidime 58 headache abdominal pain 58 An ArteFill Skin 58 HYVISC ® treatment 58 EXPLORE Xa 58 pegylated interferons 58 Monotherapy 58 Amgen Neulasta ® 58 oral proteasome inhibitor 58 midstage clinical 58 Enzo Biochem Reports 57 5q MDS 57 Statistically Significant Improvement 57 inhibit platelet function 57 riociguat 57 IIa Clinical Trial 57 Dose Escalation 57 chemosensitizer 57 ABSORB clinical 57 endocrinology orthopedics kidney 57 MyVax R 57 induced tumor regression 57 Appears Safe 57 Temsirolimus 57 Sudhir Agrawal D.Phil 57 severe hypercholesterolemia 57 octreotide implant 57 Michael Smerconish writes 57 lymphoid cancers 57 pyrimidine nucleoside analog 57 Patients Suffering 57 demonstrated clinically meaningful 57 Adjunctive Therapy 57 Zemiva TM 57 leading oral taxane 57 Drug Combo 57 zileuton injection 57 metastatic colorectal carcinoma 57 Soluble CD# 57 SORT OUT III 57 Neuvenge 57 gluteal injection 57 By MICHAEL RADANO 57 clinical trials dacetuzumab SGN 57 Collaborators Present 57 Aptivus ® 57 clinical trials Archexin ® 57 AFREZZA ™ 57 vinorelbine tartrate 57 Well Tolerated 57 dopamine receptor agonist 57 herpes zoster shingles 57 Xanafide 57 TOLAMBA 57 sells Osteocel R 57 elacytarabine 57 Cinquil 57 Levels Linked 57 Phase IIIb clinical 57 candidate Zelrix 57 PEGylated anti 57 Voreloxin 57 hypoxia activated prodrug 57 HQK 57 Aflibercept 57 refractory NSCLC 57 AML MDS 57 deCODE Glaucoma TM 57 proprietary intravenous formulation 57 TTR amyloidosis 57 Relapsed Refractory Aggressive 57 Treatment Regimen 57 identify protein biomarkers 57 MEK inhibitors 57 selective angiogenic kinase inhibitor 57 either acutely decompensated 57 Vaccine Candidate 57 AVI antiviral programs 57 multitargeted 57 Lowers Risk 57 Independently Dyax 57 dihydrochloride Tablets 57 BiovaxID TM 57 Predict Risk 57 www.ingenuity.com 57 Psoriasis Drug 57 FACTIVE ® 57 initiate Phase 2b 57 Lupus Nephritis 57 Clot busting 57 TNF alpha selectively neutralizing 57 essential thrombocythemia ET 57 Novel Compound 57 gastroenteritis conjunctivitis 57 Metformin GR 57 Oracea TM 57 diagnostic molecular imaging 57 unresectable stage 57 including acne photodamage 57 somatostatin analog 57 mGluR5 antagonists 57 novel nucleoside analog 57 Oxytrex TM 57 Derma Sciences Announces 57 Corcept Therapeutics Announces 57 sarcoma melanoma 57 Alemtuzumab 57 thetreatment 57 Cardiotoxicity 57 Phase IIa Clinical Trial 57 Demonstrates Potential 57 OncoVex 57 PEGylated interferon 57 Ciclesonide 57 Phase 2b Study 57 mocetinostat MGCD# 57 using VIAdel TM 57 virologically suppressed 57 ankylosing spondylitis psoriatic arthritis 57 Prostate AdenoCarcinoma Treatment 57 Platinol ® cisplatin 57 Receives CE Marking 57 rubella hepatitis 57 Alzhemed TM 57 Symbicort combine 57 Treatment Experienced 57 anti atherothrombotic 57 ZALBIN 57 leukemia multiple myeloma 57 selective androgen receptor modulator 57 Optiquel ™ 57 interferon beta 1a infertility 57 multicenter Phase III 57 Cervical Dysplasia 57 Vicor Technologies Announces 57 Levoleucovorin 57 Companion Diagnostic 57 Nasal spray flu 57 Find xp 57 administered concomitantly 57 Cloretazine ® 57 Gene Variation 57 vaginal candidiasis 57 clinically contraindicated 57 IMiDs ® compound 57 OvaRex R 57 Detect Lung Cancer 57 GRALISE 57 Infected Patients 57 prednisone prednisolone plus 57 CD4 monoclonal antibody 57 VANTAS ® 57 By Christine Fenno 57 gastroenterology neurology 57 RECORD1 57 volociximab 57 By CITIZEN STAFF 57 Intravenous immunoglobulin 57 Simulect 57 active ankylosing spondylitis 57 ALN PCS 57 Aurora Kinase 57 LHRH receptor positive 57 Saltalamacchia Vazquez 57 Prolongs Life 57 HDL Selective Delipidation 57 cytomegalovirus retinitis 57 Significantly Improved 57 sapropterin dihydrochloride Tablets 57 commercializing Loramyc ® 57 Initiate Phase II 57 Flu Strains 57 sickle cell cystic fibrosis 57 phase IIb clinical 57 cyclophosphamide doxorubicin vincristine 57 TNF antagonist therapy 57 autoimmune uveitis 57 carcinoma mCRC 57 Aztreonam Lysine 57 cancer neuroendocrine tumor 57 STELARA ® 57 Oglemilast 57 prescribed proton pump 57 Clinical Validation 57 Omigard TM 57 Quinamed 57 inhibits blood clotting 57 formerly LymphoStat B 57 Acute Attacks 57 tyrosine kinase inhibitor TKI 57 Our BOOSTCAP R 57 Retisert R 57 pharmacokinetic PK study 57 intranasal formulation 57 5 HT3 antagonist 57 canakinumab 57 Invasive fungal infections 57 arthritis RA 57 forodesine hydrochloride 57 Talabostat 57 MKC# MKC# PP 57 Tarvacin Anti Cancer 57 receiving immunosuppressive therapy 57 IV APAP 57 Myeloma Patients 57 EGFR TKI 57 Firdapse TM amifampridine phosphate 57 Artificial pancreas 57 containing LABAs 57 NR2B selective 57 Apoptone HE# 57 Arrhythmogenic 57 venous stasis ulcers 57 SIMPONI TM 57 candidates Azedra 57 polyneuropathy HIV DSP 56 Carbidopa Levodopa 56 treat chronic sinusitis 56 Bezielle 56 K ras mutations 56 Nasulin ™ 56 Hospital Acquired Pneumonia 56 candidate REP# 56 faropenem 56 Significantly Improves 56 Please respond insightfully 56 Renal Cell Carcinoma 56 spinal stenosis degenerative disc 56 HCV protease inhibitors 56 patients coinfected 56 haematologic 56 molecular imaging radiopharmaceuticals 56 rheumatoid arthritis lupus 56 arthritis PsA 56 Anemia Drug 56 modified glutathione analog 56 indications Dupuytren 56 docetaxel Taxotere ® 56 PMX # heptagonist 56 ALN HTT 56 MKC# 56 weekly subcutaneous injections 56 Chronic Sinusitis 56 Pegylated 56 Crizotinib 56 severe hepatic dysfunction 56 Argatroban 56 rusalatide acetate 56 neurodegenerative disorder characterized 56 dermatologic reactions 56 lymphomas leukemias 56 acute porphyria 56 Heartburn Drugs 56 RhuDex 56 Anxiety cinches 56 Curis collaborator Genentech 56 markets HP Acthar 56 ORAL Sync 56 Raloxifene STAR 56 mGluR2 positive 56 DURECT proprietary 56 Spiegelmer ® 56 instrument SHORT TERM 56 Diffuse Large B 56 Farouk# writings offer 56 reactogenicity 56 CIMZIA r 56 antiretroviral naïve 56 ritonavir boosted 56 transthyretin mediated amyloidosis ATTR 56 leukemia lymphoma multiple myeloma 56 molecular chaperone regulation 56 designed chimeric peptide 56 gastrointestinal stromal 56 treats acute lymphoblastic 56 8mg/kg 56 Dacetuzumab